These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 36914214

  • 1. Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
    Lok SWY, Yiu WH, Zou Y, Xue R, Li H, Ma J, Chen J, Chan LYY, Lai KN, Tang SCW.
    Nephrol Dial Transplant; 2023 Sep 29; 38(10):2232-2247. PubMed ID: 36914214
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.
    Rodríguez-Romo R, Benítez K, Barrera-Chimal J, Pérez-Villalva R, Gómez A, Aguilar-León D, Rangel-Santiago JF, Huerta S, Gamba G, Uribe N, Bobadilla NA.
    Kidney Int; 2016 Feb 29; 89(2):363-73. PubMed ID: 26509589
    [Abstract] [Full Text] [Related]

  • 8. LTBP4 Protects Against Renal Fibrosis via Mitochondrial and Vascular Impacts.
    Su CT, See DHW, Huang YJ, Jao TM, Liu SY, Chou CY, Lai CF, Lin WC, Wang CY, Huang JW, Hung KY.
    Circ Res; 2023 Jun 23; 133(1):71-85. PubMed ID: 37232163
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A single administration of FGF2 after renal ischemia-reperfusion injury alleviates post-injury interstitial fibrosis.
    Tan X, Tao Q, Yin S, Fu G, Wang C, Xiang F, Hu H, Zhang S, Wang Z, Li D.
    Nephrol Dial Transplant; 2023 Oct 31; 38(11):2537-2549. PubMed ID: 37243325
    [Abstract] [Full Text] [Related]

  • 15. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
    Lee J, Lee J, Kim K, Lee J, Jung Y, Hyeon JS, Seo A, Jin W, Weon B, Shin N, Kim S, Lim CS, Kim YS, Lee JP, Hwang GS, Yang SH.
    Kidney Int; 2024 Jun 31; 105(6):1239-1253. PubMed ID: 38431216
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiapoptotic Effect by PAR-1 Antagonist Protects Mouse Liver Against Ischemia-Reperfusion Injury.
    Noguchi D, Kuriyama N, Ito T, Fujii T, Kato H, Mizuno S, Sakurai H, Isaji S.
    J Surg Res; 2020 Feb 31; 246():568-583. PubMed ID: 31653415
    [Abstract] [Full Text] [Related]

  • 19. TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment.
    Abdelmageed MM, Kefaloyianni E, Arthanarisami A, Komaru Y, Atkinson JJ, Herrlich A.
    Nephrol Dial Transplant; 2023 May 04; 38(5):1139-1150. PubMed ID: 36269313
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.